Our mission is to accelerate regenerative medicine to improve health and deliver cures

TOWARDS A REGENERATIVE MEDICINE

COLLECT OPPORTUNITIES
EXPAND KNOWLEDGE
FORGE COLLABORATIONS
DELIVER CURES
previous arrow
next arrow
Slider

Regenerative Medicine

A new paradigm of medicine that relies on stem cells capacity to regenerate, regrow, and fully heal damaged tissues and organs in our bodies

Ethical Advancement

We are committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies.

Improve Health

All we do is in service of health, life, and the alleviation of human suffering

Deliver Cures

Alleviating the suffering and restoring the hope of patients, and of their loved ones, is what fuels our passion and our work.

Regenerative Medicine News

Interview: Dr. Anthony Atala discusses the future of regenerative medicine

Interview: Dr. Anthony Atala discusses the future of regenerative medicine

By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest...
Joe and Jill Biden among several honored at World Stem Cell Summit gala

Joe and Jill Biden among several honored at World Stem Cell Summit gala

By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 –  Greg Simon, president of the Biden Cancer...

Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

MIAMI, Jan. 22, 2018 /PRNewswire/ -- Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when...

Longeveron Aging Frailty Phase 2b Trial

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron...

Longeveron Alzheimer’s Disease Trial

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized,...

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people....
Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit

PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading...
Mayo Clinic

Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit

The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the...

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

January 18, 2018 - Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease - a life-threatening condition caused by the loss of...

Pioneers of Hope: Patient Advocate Doug Oliver’s Interview of Dr. Francis Collins, Director, National Institutes of Health (NIH)

The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with...
Image is not available
Looking to the Future of Medicine

Millions of people all over the world who have conditions that today are considered incurable look towards Regenerative Medicine for solutions and hope.

Image is not available
What Fuels Our Passion

Alleviating the suffering and restoring the hope of patients, and of their loved ones, is what fuels our passion and our work.

Image is not available
Bringing Together Thought Leaders

RMF brings together professionals, researchers, institutions, legal practices, patient advocacy groups, philanthropies, business people and policymakers.

previous arrow
next arrow
Slider

What We Do

Conferences

We Produce the World Stem Cell Summit, the RegMed Capital Conference, the Stem Cell Action Awards, and other events.

Patient Advocacy

We are trusted brokers of relationships and information between patient groups and stakeholders in the field, promoting advances towards delivery of new treatments and cures.

Policy

Since 2003 we have a track record fostering a supportive regulatory and societal framework for regenerative medicine.

Outreach

We educate and inform the public and build societal support through our network and communication channels.

A Trusted Network

Regenerative Medicine Foundation unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations.

Signup Today For News and Updates

Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.

The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.